Jiangchuan

Jiangchuan (Beijing) Biotechnology is a high-tech life sciences company specializing in precision medicine and molecular diagnostics for oncology and infectious diseases. Headquartered in Beijing, the company focuses on the development and commercialization of advanced diagnostic kits and reagents utilizing next-generation sequencing (NGS), real-time PCR, and liquid biopsy technologies. Its clinical portfolio is primarily designed for the detection of actionable mutations in solid tumors, such as non-small cell lung cancer and colorectal cancer, to guide personalized treatment strategies. Beyond its diagnostic products, Jiangchuan provides comprehensive genomic profiling services and serves as a significant supplier of laboratory reagents to hospitals and research institutions. The company is a recognized player in China's molecular pathology sector, bridging the gap between genomic research and clinical application.